Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
09/2003
09/18/2003CA2475254A1 Pyridinyloxy derivatives as 5-ht receptor ligands
09/18/2003CA2459834A1 Citalopram for the treatment of elevated blood pressure
09/18/2003CA2423259A1 New compounds derived from quinazoline, the process for preparing them, and the pharmaceutical compositions containing them
09/17/2003EP1344823A1 Novel g protein-coupled receptor proteins and dnas thereof
09/17/2003EP1344779A1 Azolo-pyrimidines
09/17/2003EP1344531A1 High molecular weight kininogen (HK) domain 5 derived peptides against thrombic diseases
09/17/2003EP1343903A1 A yeast expression vector and a method of making a recombinant protein by expression in a yeast cell
09/17/2003EP1343900A2 Oxidoreductases
09/17/2003EP1343888A2 Regulation of human chemokine-like receptor
09/17/2003EP1343876A2 Modulators of activity of g-protein-coupled receptor kinases
09/17/2003EP1343813A1 Novel compounds
09/17/2003EP1343803A2 2-substituted estrogens as antiangiogenic agents
09/17/2003EP1343789A1 Tricyclic derivatives of indole with antiangiogenic activity
09/17/2003EP1343786A1 Novel pyridine-substituted pyrazolopyridine derivatives
09/17/2003EP1343782A1 Pyrimidineamines as angiogenesis modulators
09/17/2003EP1343781A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
09/17/2003EP1343779A2 Novel compounds
09/17/2003EP1343778A2 Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists
09/17/2003EP1343775A2 Piperazine derivatives
09/17/2003EP1343773A1 Thiazole derivatives for traeing ppar related disorders
09/17/2003EP1343769A1 Benzoylpyridazines
09/17/2003EP1343764A1 Urea and urethane derivatives as integrin inhibitors
09/17/2003EP1343763A1 Pyrodone derivatives as ap2 inhibitors
09/17/2003EP1343759A1 Benzo(f) isoindol derivatives and their use as ep4 receptor ligands
09/17/2003EP1343757A1 Indole derivatives
09/17/2003EP1343751A2 Cyclic derivatives as modulators of chemokine receptor activity
09/17/2003EP1343561A1 Serine protease inhibitors
09/17/2003EP1343544A2 Uses of a medical device having a lubricious, nitric oxide-releasing coating for the therapy of vascular disorders
09/17/2003EP1343530A1 Oral pharmaceutical composition containing a block copolymer
09/17/2003EP1343529A2 Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
09/17/2003EP1343520A2 New therapeutic uses of smr1 peptides
09/17/2003EP1343519A2 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders
09/17/2003EP1343517A2 Survical promoting ncam binding and ncam ligand biding compounds
09/17/2003EP1343513A1 Compositions containing an active fraction isolated from scutellariae barbatae and methods of use
09/17/2003EP1343509A2 Combination of an estrogen and an androgen for treating hormonal deficiencies in women undergoing estrogen replacement therapy
09/17/2003EP1343506A1 Pharmaceutical formulation containing pyrazolo 4,3-d]pyrimidines and antithrombotic agents, calcium-antagonists, prostaglandins or prostaglandin derivatives
09/17/2003EP1343505A1 Cxcr3 antagonists
09/17/2003EP1343503A1 Heteroaryl urea neuropeptide y y5 receptor antagonists
09/17/2003EP1343501A1 Therapy for herpes neurological viral conditions utilizing 1,4-dihydropyridine calcium channel blockers
09/17/2003EP1343490A1 Choline pyruvate, method for the production thereof, formulations containing choline pyruvate and the use thereof
09/17/2003EP1343488A1 Treatment of statin side effects
09/17/2003EP1343487A2 Methods and compositions to treat conditions associated with neovascularization
09/17/2003EP1343485A2 Lipid-based nitric oxide donors
09/17/2003EP1343473A1 Pharmaceutical dronedarone composition for parenteral administration
09/17/2003EP1314426A9 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
09/17/2003EP1282622B1 Crf receptor antagonists and methods relating thereto
09/17/2003EP1244452B1 Carboxamide derivates of pyrrolidine and piperidine as urotensin-ii receptor antagonists
09/17/2003EP1224174B1 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
09/17/2003EP1224166B1 Method of producing n-(4,5-bis-methanesulfonyl-2-methyl-benzoyl)-guanidine, the hydrochloride thereof
09/17/2003EP1200445B1 Thienopyranecarboxamide derivatives
09/17/2003EP1196411B1 Bradykinin b1 receptor antagonists
09/17/2003EP1192163B1 DITHIEPINO 6,5-b]PYRIDINES, AND RELATED COMPOSITIONS AND METHODS
09/17/2003EP1183241B1 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
09/17/2003EP1159295B1 Method of purifying whey of lactic acid fermentation by electrodialysis
09/17/2003EP1133471B1 Hydrazine derivatives
09/17/2003EP1123296B1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION
09/17/2003EP1095021B1 Quinoline derivatives
09/17/2003EP1023267B1 Pyridyl compounds and pharmaceutical compositions containing them
09/17/2003EP0996446B1 Novel substituted imidazole compounds
09/17/2003EP0891329B1 Peptidyl compounds having mmp and tnf inhibitory activity
09/17/2003EP0769940B1 INDENE sPLA2 INHIBITORS
09/17/2003EP0768089B1 Hot water extract of Cordyceps sinensis
09/17/2003EP0724647A4 Nucleic acid ligands and improved methods for producing the same
09/17/2003EP0571613B1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
09/17/2003CN1443199A Antibodies to human MCP-1
09/17/2003CN1443187A Fused cyclic compounds as modulators of nuclear hormone receptor function
09/17/2003CN1443184A 嘧啶衍生物 Pyrimidine derivatives
09/17/2003CN1443179A Aniline derivatives
09/17/2003CN1443178A (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphtyl] -4-morpholibenzamide
09/17/2003CN1443176A Valsartan salts
09/17/2003CN1443173A Substituted imidazoles as TAFI a inhibitors
09/17/2003CN1443167A Azacyclic compounds for use in treatment of 5-serotonin related diseases
09/17/2003CN1443164A Pyrrolidine derivatives as metalloprotease inhibitors
09/17/2003CN1443163A Pyrrolidine-2-carboxylic acid hydrozide derivatives for use as metalloprotease inhibitors
09/17/2003CN1443160A N-substituted-1-amino-1,1-dialkyl carboxylic acid derivatives
09/17/2003CN1443155A Compounds to treat alzheimer's disease
09/17/2003CN1443074A Methods and compositions for inhibiting immunoglobulin-mediated reperfusion injury
09/17/2003CN1443070A Apoptosis inhibiting composition comprising 15-keto-prostaglandin or derivative thereof
09/17/2003CN1443069A Sustained release ranolazine formulations
09/17/2003CN1443065A Pharmaceutical composition improved in peroral absorbability
09/17/2003CN1442415A Preparation method of iso propylidene shikimic acid and its new use
09/17/2003CN1442202A Biological preparation for preventing and treating heart and brain blood vessel disease and its application
09/17/2003CN1442197A New use of agastache rugosus oil
09/17/2003CN1442191A Synergistic safflower soluble suppository preparation
09/17/2003CN1442190A Chinese medicine possessing kidney supplementing brain fortifying, statis transforming and vessel freeing actions
09/17/2003CN1442186A Medicine for treating coronary disease and its preparation method
09/17/2003CN1442183A Application of tongsaimai ectract in preparation of meticine for treating celebral wind stroke
09/17/2003CN1442167A Making method of capsule for treating hemorrhoid
09/17/2003CN1442162A Medicine for treating cor pulmonale and its preparation method
09/17/2003CN1442161A Pad for lowering blood viscous and blood fat
09/17/2003CN1442148A Daidzein drip pill and its preparation method
09/17/2003CN1442147A Erigeron breviscapus liposome and its freeze dried powder injection fluid and preparation method
09/17/2003CN1442145A Aspilrin slow release tablet
09/17/2003CN1442141A Ferulic acid salt injection agent
09/17/2003CN1442139A Medicinal composition for treating inflammation
09/17/2003CN1442137A Crataegus leaf total flarone powder injection for treating heart and brain blood vessel disease and its preparation method
09/17/2003CN1121415C Chitoser ester and its preparing process and application
09/17/2003CN1121403C Quinoxalinediones
09/17/2003CN1121402C Crystals of piperdine derivatives, intermediates for production of same, and process for producing the same
09/17/2003CN1121230C Applexy treating capsule
1 ... 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 ... 1595